Cara therapeutics stock price target

The 9 analysts offering 12-month price forecasts for Cara Therapeutics Inc have among 9 polled investment analysts is to Buy stock in Cara Therapeutics Inc. Based on 3 analysts offering 12 month price targets for Cara Therapeutics in the last 3 months. The average price target is $31.67 with a high forecast of $35.00 

View detailed financial information, real-time news, videos, quotes and analysis on CARA Therapeutics Inc. (NASDAQ:CARA). Explore commentary on CARA Therapeutics Inc. and hear what the experts at CARA: Cara Therapeutics Inc - Stock Price, Quote ... - CNBC Get Cara Therapeutics Inc (CARA:NASDAQ) real-time stock quotes, news and financial information from CNBC. Expensive Market, What To Buy? Cara Therapeutics Inc ... Mar 09, 2020 · Laidlaw advised investors in its research note published on May 29, 2019, to Buy the CARA stock while also putting a $32 price target. The stock had earned Buy rating from Jefferies Markets when it published its report on February 06, 2019. That day the Jefferies set price target on the stock to $22.

Find real-time CARA - Cara Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. CARA - Cara Therapeutics Inc Stock quote - CNNMoney.com Markets

4 analysts have issued 12-month price targets for Cara Therapeutics' shares. Their forecasts range from $30.00 to $39.00. On average, they anticipate Cara  Find the latest analyst research for Cara Therapeutics, Inc. Common Stock ( CARA) at Nasdaq.com. Analyst price targets provided by TipRanks. At $85.83, the average price target implies 50% upside potential. (See MyoKardia stock analysis on TipRanks)Cara Therapeutics (CARA)By developing a class  CARA | Complete Cara Therapeutics Inc. stock news by MarketWatch. View real- time stock prices and stock quotes for a full financial overview. products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. Cara Therapeutics Inc. analyst estimates by MarketWatch. View CARA Average Recommendation: Buy, Average Target Price: 32.11 Earnings Per Share  Cara Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CARA updated stock price target summary. Company Name: Cara Therapeutics Inc., Stock Symbol: CARA, Industry: Biotechs , Total Analysts' Ratings History for Cara Therapeutics (NASDAQ:CARA) 

Sep 25, 2018 · A completed technical price pattern on the Cara Therapeutics Inc (NASDAQ:CARA) stock chart is suggesting that higher CARA stock prices are on the horizon.

Sep 25, 2018 · A completed technical price pattern on the Cara Therapeutics Inc (NASDAQ:CARA) stock chart is suggesting that higher CARA stock prices are on the horizon. NASDAQ | CARA: Cara Therapeutics Stock News, Ratings ... Looking for insights on Cara-therapeutics (NASDAQ:CARA) stock? View CARA's stock ratings, price targets, earnings, commentary and news at Smarter Analyst. Is A Downturn Overdue? Cara Therapeutics Inc. (NASDAQ:CARA ... Mar 18, 2020 · The shares of Cara Therapeutics Inc. (NASDAQ:CARA) has been pegged with a rating of Buy by H.C. Wainwright in its latest research note that was published on August 12, 2019. The Healthcare company has also assigned a $30 price target.

View the latest CARA stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of CARA THERAPEUTICS, INC..

This Matters Too Much For Cara Therapeutics (CARA ... Mar 09, 2020 · Cara Therapeutics (CARA) Technical Analysis. Based on the latest results, analysts are suggesting that the target price for VNE stock should be $10.08 per share in the course of the next 12 months. To achieve the target price as suggested by analysts, VNE should have a spike by 0% in oppose to its present value in the market. Stock Information | Cara Therapeutics The Investor Relations website contains information about Cara Therapeutics's business for stockholders, potential investors, and financial analysts. Cara Therapeutics Inc (NASDAQ:CARA) price target set to ... Nov 07, 2018 · Today, Cantor Fitzgerald set its price target on Cara Therapeutics Inc (NASDAQ:CARA) to $27.00 per share. There are 9 Buy Ratings, 2 Hold Ratings, no …

CARA - Stock quote for CARA THERAPEUTICS, INC. - MSN Money

This Matters Too Much For Cara Therapeutics (CARA ... Mar 09, 2020 · Cara Therapeutics (CARA) Technical Analysis. Based on the latest results, analysts are suggesting that the target price for VNE stock should be $10.08 per share in the course of the next 12 months. To achieve the target price as suggested by analysts, VNE should have a spike by 0% in oppose to its present value in the market. Stock Information | Cara Therapeutics

Description: Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. CARA - Cara Therapeutics Stock Price - Barchart.com Cara Therapeutics (CARA) Reports Q4 Loss, Misses Revenue Estimates Zacks Equity Research - Zacks Investment Research It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by … This Matters Too Much For Cara Therapeutics (CARA ... Mar 09, 2020 · Cara Therapeutics (CARA) Technical Analysis. Based on the latest results, analysts are suggesting that the target price for VNE stock should be $10.08 per share in the course of the next 12 months. To achieve the target price as suggested by analysts, VNE should have a spike by 0% in oppose to its present value in the market. Stock Information | Cara Therapeutics The Investor Relations website contains information about Cara Therapeutics's business for stockholders, potential investors, and financial analysts.